Fig. 1

The expression level of the UBE2T gene in different tumors and pathological stages. A The expression of the UBE2T gene in 33 different types of tumors and normal tissues in the TCGA database (https://portal.gdc.cancer.gov/). B For certain tumors without normal or with few normal tissues (n < 3), the Gene Expression Profiling Interactive Analysis (GEPIA) web tool (http://gepia.cancer-pku.cn/) was used to compare the UBE2T expression between these tumor tissues and the corresponding normal tissues from the Genotype-Tissue Expression (GTEx) database. (https://www.genome.gov/Funded-Programs-Projects/Genotype-Tissue-Expression-Project). C Based on the UALCAN database (http://ualcan.path.uab.edu/analysis-prot.html), we compared UBE2T protein expression levels between tumor and respective normal tissues for LUAD, OV, RCC, and UCEC. D Using the TCGA data, the expression levels of the UBE2T gene were determined in stages I, II, III, and IV). Log2 (TPM + 1) was applied for the log scale. E The subcellular localization of UBE2T in tumor cells was visualized (HPA database) (https://www.proteinatlas.org/). Red and green fluorescence represent microtubules and UBE2T, respectively). *p < 0.05; **p < 0.01; ***p < 0.001